🇺🇸 FDA
Patent

US 8258148

Spiroindoline modulators of muscarinic receptors

granted A61KA61K31/435A61K31/438

Quick answer

US patent 8258148 (Spiroindoline modulators of muscarinic receptors) held by Vertex Pharmaceuticals Incorporated expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Sep 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
29
CPC classes
A61K, A61K31/435, A61K31/438, A61K31/4747, A61K31/55